Yatharth Hospitals Q4 FY26: Sales up 47%, profit 23%

Key takeaway from the March 2026 quarter

Yatharth Hospital and Trauma Care Services (Yatharth Hospitals) reported a sharp rise in consolidated revenue for the March 2026 quarter, driven by higher sales from operations and traction at newer units. Net sales came in at Rs 341.56 crore, up 47.36% year-on-year from Rs 231.78 crore in the March 2025 quarter. Consolidated net profit rose to Rs 47.52 crore, up 22.73% from Rs 38.72 crore a year ago. The operating profit line also improved, with EBITDA at Rs 87.02 crore, up 39.52% from Rs 62.37 crore.

Stock reaction and trading levels

Following the quarterly update, Yatharth Hospitals’ stock was reported to have risen 1.60% to Rs 833.25. Separately, the stock was reported to have closed at Rs 820.55 on May 22, 2026 on the NSE. The company trades under NSE: YATHARTH and BSE: 543950, and is classified in the Hospital & Healthcare Services sector.

Q4 FY26 operational and profitability metrics

The March quarter also showed an improvement in earnings per share, with EPS at Rs 4.93 versus Rs 4.37 in March 2025. A performance table in the data set reported OPM at 23.40% for the quarter versus 24.61% a year earlier. The same table reported PBDT at Rs 81.95 crore (up from Rs 61.40 crore) and PBT at Rs 51.95 crore (up from Rs 48.53 crore). These figures indicate that profitability improved in absolute terms alongside revenue, even as the operating margin percentage was lower year-on-year.

Full-year FY26: revenue crosses Rs 1,200 crore

For the full year ended March 2026, the company reported consolidated net profit of Rs 175.38 crore, up 34.34% from Rs 130.55 crore in FY25. Full-year sales rose 37.10% to Rs 1,207.17 crore from Rs 880.49 crore in FY25. Another summary in the provided text separately stated FY26 net profit at Rs 170.3 crore (up 30.45% year-on-year), while keeping total revenue at Rs 1,207.17 crore. The dataset also reported FY26 OPM at 24.20% versus 25.01% in FY25, with PBDT at Rs 311.37 crore and PBT at Rs 223.56 crore for FY26.

What the company said about growth drivers

According to the company’s earnings statement quoted in the provided material, revenue growth in the March quarter was supported by “strong traction across newer hospitals in Greater Faridabad, Faridabad and Agra”. These newer hospitals contributed Rs 75.3 crore in revenues, representing 22% of the Group’s revenues for the period cited. The statement also said existing hospitals reported 29% year-on-year revenue growth. The disclosures suggest a mix of ramp-up at newer facilities and steady growth in the core network.

Quarterly trend: March vs December snapshot

The consolidated quarterly results table in the provided text listed net sales for the December 2025 quarter at Rs 320.47 crore, compared with Rs 341.56 crore in March 2026 and Rs 231.78 crore in March 2025. This provides a simple view of the step-up in scale across the year.

Summary table: Q4 FY26 vs Q4 FY25 and FY26 vs FY25

The following table consolidates the key figures and percentage changes explicitly stated in the provided content.

Context: earlier-quarter reference points mentioned

The dataset also referenced Q3 FY26 highlights in a separate note: consolidated revenue of INR 3,205 million (Rs 320.5 crore), up 46% year-on-year, and 9M FY26 revenue of INR 8,577 million (Rs 857.7 crore), up 32% year-on-year. It also cited EBITDA of INR 742 million (Rs 74.2 crore) and PAT of INR 431 million (Rs 43.1 crore) for Q3 FY26. While these figures are for a different quarter than the March results, they align with the broader picture of higher revenue scale through FY26.

Other disclosed market datapoints in the provided text

The provided material included a stated market capitalisation of Rs 7,902.02081757 crore (as per a referenced source in the text), and noted promoter holding at 55.80% in the March 2026 quarter. It also stated total debt at Rs 0 crore (as per the same referenced source). These figures are presented as reported in the supplied dataset.

What investors may track next

The March quarter numbers highlight that Yatharth Hospitals expanded revenue sharply year-on-year, alongside higher profit and EBITDA in absolute terms. With management commentary pointing to contributions from newer hospitals in Greater Faridabad, Faridabad and Agra, subsequent updates on revenue mix and ramp-up at these facilities will remain a key datapoint. Investors will also watch how margins evolve given the year-on-year change in operating margin percentage reported in the table. The next formal checkpoint will be the company’s subsequent quarterly results announcement.